University of Cambridge > Talks.cam > GIPA seminar series > Genetic Engineering of Hematopoiesis to treat inherited diseases and cancer

Genetic Engineering of Hematopoiesis to treat inherited diseases and cancer

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Luigi Aloia.

Prof. Naldini described for the first time the use of lentiviral vectors for gene transfer into non-dividing cells in 1996. He is a leading scientist in the field of gene therapy with the final goal of therapeutic translation. The team led by Prof. Naldin

Abstract not available

This talk is part of the GIPA seminar series series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2019 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity